StrataGent Life Sciences
Los Gatos
About StrataGent Life Sciences
StrataGent Life Sciences, Inc. is a specialty drug therapy company developing painless, non-invasive versions of therapies that would otherwise be injected. Its products are based on its proprietary microjet technology, which delivers large and small therapeutic molecules without a device penetrating into or through the skin. In May of 2004, StrataGent received a $2 million award from the Advanced Technology Program (ATP) at the National Institute of Standards and Technology to support the development of the StrataGent microjet technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $18.0M
- Funding stage: M&A
- Last round: Series B (May 2007)
- Website: stratagentlifesciences.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/stratagent-life-sciences-2671694 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.